You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunotherapy Resistance

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer Patients Trial in Jinan (Low-dose radiotherapy combined with conventional fractionated radiotherapy)

Recruiting
  • Cancer Patients
  • Low-dose radiotherapy combined with conventional fractionated radiotherapy
  • Jinan, In Shandong Province, China
    The First Affiliated Hospital of Shandong First Medical Universi
Jun 7, 2023

Advanced Melanoma

Enrolling by invitation
  • Melanoma
  • observational
  • Durham, North Carolina
    Duke University Medical Center
Aug 16, 2022

Metastatic Extracranial Malignant Solid Tumor, Radiotherapy, Immune Checkpoint Blockade Trial in Shantou (Intestinal Low Dose

Not yet recruiting
  • Metastatic Extracranial Malignant Solid Neoplasm
  • +3 more
  • Intestinal Low Dose Radiotherapy-1Gy
  • +3 more
  • Shantou, Guangdong, China
    Cancer Hospital, Shantou University Medical College
Oct 7, 2023

Microenvironment of Lung Cancer and Exploration of Mechanism of

Recruiting
  • Lung Cancer
  • Multiomics analysis
  • Yiwu, Zhejiang, China
    The Fourth Affiliated Hospital of Zhejiang University
Dec 16, 2022

Clear Cell Renal Cell Carcinoma?Resistance to Immunotherapy Trial in Shanghai (AK104(anti-PD-1/CTLA-4 bi-specific antibody

Recruiting
  • Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
  • AK104（anti-PD-1/CTLA-4 bi-specific antibody ，intravenously）,lenvatinib（ targeted VEGFR 1-3、FGFR、PDGFRα， small molecule TKI，orally
  • Shanghai, Shanghai, China
    Shanghai Renji Hospital
Sep 12, 2023

HCC Trial in Hong Kong (Zabadinostat (CXD101) and Geptanolimab, Lenvatinib and Sorafenib)

Not yet recruiting
  • HCC
  • Zabadinostat (CXD101) and Geptanolimab
  • Lenvatinib and Sorafenib
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Prince of Wales Hospital
May 15, 2023

Lymphoma, Leukemia, Myeloma Trial in Tampa (Resistance Training, Aerobic Exercise)

Recruiting
  • Lymphoma
  • +2 more
  • Resistance Training
  • Aerobic Exercise
  • Tampa, Florida
    Moffitt Cancer Center
Feb 28, 2023

Malignant Melanoma, Metastatic Melanoma, Immunotherapy Trial (Pembrolizumab, Encorafenib, Binimetinib)

Not yet recruiting
  • Malignant Melanoma
  • +4 more
  • (no location specified)
Mar 31, 2022

Immunotherapy Trial in Heidelberg (Fecal microbiota transfer, Vancomycin Oral Capsule, Atezolizumab + Bevacizumab)

Not yet recruiting
  • Immunotherapy
  • Fecal microbiota transfer
  • +4 more
  • Heidelberg, Baden-Württemberg, Germany
  • +1 more
Jan 19, 2023

Cutaneous Melanoma Trial in Paris (Blood sample, Cutaneous melanoma biopsy)

Recruiting
  • Cutaneous Melanoma
  • Blood sample
  • Cutaneous melanoma biopsy
  • Paris, Ile De France, France
    Dermatology department
Oct 24, 2022

Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial (Nivolumab,

Withdrawn
  • Lung Non-Small Cell Carcinoma
  • +12 more
  • (no location specified)
May 24, 2022

Colon Cancer, Liver Metastasis Colon Cancer, Rectal Cancer Trial in Ramat Gan (Hepatopulmonary radio-sterilization)

Not yet recruiting
  • Colon Cancer
  • +2 more
  • Hepatopulmonary radio-sterilization
  • Ramat Gan, Israel
    Sheba Medical Center
Sep 21, 2023

Cancer Patients Trial in Jinan (At the same time, the original regimen of immunomaintenance therapy was continued, according to

Recruiting
  • Cancer Patients
  • At the same time, the original regimen of immunomaintenance therapy was continued, according to the frequency of the original immunization regimen once every 3 weeks until progress.
  • Jinan, In Shandong Province, China
    The First Affiliated Hospital of Shandong First Medical Universi
Sep 16, 2022

Molecular Subtyping of Extensive Stage Small Cell Lung Cancer

Recruiting
  • SCLC,Extensive Stage
  • PD-(L)1 antibody immunotherapy
  • Beijing, Beijing, China
    Peking University Cancer Hospital & Institute
Jul 3, 2023

Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays

Not yet recruiting
  • Lung Neoplasm
  • +2 more
  • Tumor samples
  • Bordeaux, France
    CHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médic
Aug 28, 2023

Lung Cancer Stage IV Trial in Maastricht (Radiation)

Not yet recruiting
  • Lung Cancer Stage IV
  • Radiation
  • Maastricht, Netherlands
    Maastricht Radiation Oncology (Maastro)
Aug 29, 2023

Carcinoma, Renal Cell, NSCLC Trial in Belgium, France (Live Bacterial Product - Akkermansia muciniphila)

Recruiting
  • Carcinoma, Renal Cell
  • Carcinoma, Non-Small-Cell Lung
  • Live Bacterial Product - Akkermansia muciniphila
  • Mons, Belgium
  • +3 more
May 9, 2023

Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT

Recruiting
  • Lung Cancer Stage III
  • Lung Cancer Stage IV
    • Brest, France
      Chu Brest
    Aug 16, 2023

    Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Laboratory Biomarker Analysis,

    Active, not recruiting
    • Advanced Malignant Neoplasm
    • +2 more
    • Laboratory Biomarker Analysis
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 13, 2022

    Immune Resistance Interrogation Study

    Recruiting
    • Cancer
    • +3 more
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Apr 7, 2022

      EGFR Activating Mutation, Recurrent Non-Small Cell Lung Carcinoma, Stage IV NSCLC Trial in Winston-Salem (drug, biological,

      Terminated
      • EGFR Activating Mutation
      • +2 more
      • Winston-Salem, North Carolina
        Comprehensive Cancer Center of Wake Forest University
      Jan 28, 2021

      Stage IIIB(N2) NSCLC, Stage IIA NSCLC, Stage IIB NSCLC Trial in Beijing (Pembrolizumab 200 mg IV infusion)

      Not yet recruiting
      • Stage IIIB(N2) Non-small Cell Lung Cancer
      • +3 more
      • Pembrolizumab 200 mg IV infusion
      • Beijing, Beijing, China
        Peking University
      May 30, 2023

      Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Tumors Trial in Melbourne

      Not yet recruiting
      • Cutaneous Squamous Cell Carcinoma
      • +3 more
      • Melbourne, Victoria, Australia
        Peter MacCallum Cancer Centre
      May 17, 2023

      Solid Tumor, Pleural Effusion, Metastasis Trial (Blood withdrawal)

      Not yet recruiting
      • Solid Tumor
      • +2 more
      • Blood withdrawal
      • (no location specified)
      Sep 9, 2022

      Metastatic Lung Cancer Trial in Beer sheva, Petah Tikva (Antibiotics, FMT (Fecal Microbiota Transplantation), Placebo

      Not yet recruiting
      • Metastatic Lung Cancer
      • Beer sheva, Israel
      • +1 more
      Aug 14, 2022